<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">37169323</PMID><DateRevised><Year>2023</Year><Month>06</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1555-7162</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2023</Year><Month>May</Month><Day>09</Day></PubDate></JournalIssue><Title>The American journal of medicine</Title><ISOAbbreviation>Am J Med</ISOAbbreviation></Journal><ArticleTitle>Long COVID Syndrome: A Case-Control Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0002-9343(23)00299-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amjmed.2023.04.022</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute coronavirus disease 2019 (COVID-19) causes various cardiovascular complications. However, it is unknown if there are cardiovascular sequelae in the medium and long-term. The aim of this study was dual. Firstly, we wanted to investigate symptomatology and health-related quality of life (HRQoL) at medium-term follow-up (6 months post-COVID). Secondly, we wanted to assess whether history of COVID-19 and persistent shortness of breath at medium-term follow-up are associated with ongoing inflammation, endothelial dysfunction, and cardiac injury.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A case-control study was performed. Virologically proven COVID-19 cases and age- and gender-matched controls were interviewed to assess symptoms and HRQoL. Biochemical tests were also performed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The study comprised 174 cases and 75 controls. The mean age of the participants was 46.1&#xb1;13.8 years. The median follow-up was 173.5 days (interquartile range 129-193.25 days). There was no significant difference in the demographics between cases and controls. At follow-up, cases had a higher frequency of shortness of breath, fatigue, arthralgia, abnormal taste of food (P &lt;.001), and anosmia. Cases also exhibited worse scores in the general health and role physical domains of the Short Form Survey-36. High-sensitivity C-reactive protein (hsCRP) was significantly higher in the cases, and there was a positive correlation of hsCRP with time. Significant determinants of shortness of breath were age, female gender and white cell count, troponin I, and lower hemoglobin levels at follow-up.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Post-COVID-19 patients have persistent symptomatology at medium-term follow-up. Higher hsCRP in cases and the positive association of hsCRP with time suggest ongoing systemic inflammation in patients persisting for months after COVID-19.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xuereb</LastName><ForeName>Rachel-Anne</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Mater Dei Hospital, Msida, Malta; University of Malta Medical School, Msida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borg</LastName><ForeName>Marica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Mater Dei Hospital, Msida, Malta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vella</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Mater Dei Hospital, Msida, Malta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gatt</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Mater Dei Hospital, Msida, Malta; University of Malta Medical School, Msida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xuereb</LastName><ForeName>Robert G</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>Mater Dei Hospital, Msida, Malta; University of Malta Medical School, Msida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbara</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Mater Dei Hospital, Msida, Malta; University of Malta Medical School, Msida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fava</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Mater Dei Hospital, Msida, Malta; University of Malta Medical School, Msida. Electronic address: stephen.fava@um.edu.mt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magri</LastName><ForeName>Caroline J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Mater Dei Hospital, Msida, Malta; University of Malta Medical School, Msida.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Med</MedlineTA><NlmUniqueID>0267200</NlmUniqueID><ISSNLinking>0002-9343</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Health-related quality of life</Keyword><Keyword MajorTopicYN="N">High-sensitivity C-reactive protein</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Troponin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>12</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>12</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>11</Day><Hour>19</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37169323</ArticleId><ArticleId IdType="pmc">PMC10168190</ArticleId><ArticleId IdType="doi">10.1016/j.amjmed.2023.04.022</ArticleId><ArticleId IdType="pii">S0002-9343(23)00299-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Institute for Health and Care Excellence. COVID-19 rapid guideline: managing the long-term effects of COVID-19. Available at:https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742. Accessed May 3, 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020;25(7):1131&#x2013;1134. 58.</Citation><ArticleIdList><ArticleId IdType="pubmed">32119647</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054&#x2013;1062.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. J Am Med Assoc. 2020;323:1061&#x2013;1069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Bader F, Manla Y, Atallah B, Starling RC. Heart failure and COVID-19. Heart Fail Rev. 2021;26:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383122</ArticleId><ArticleId IdType="pubmed">32720082</ArticleId></ArticleIdList></Reference><Reference><Citation>Italia L, Tomasoni D, Bisegna S, Pancaldi E, Stretti L, Adamo M, Metra M. COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae. Front Cardiovasc Med. 2021;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8382715</ArticleId><ArticleId IdType="pubmed">34447795</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl K, Br&#xe4;sen JH, Hoeper MM, David S. Direct evidence of SARS-CoV-2 in gut endothelium. Intensive Care Med. 2020;23:1&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7483488</ArticleId><ArticleId IdType="pubmed">32915253</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417&#x2013;1418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Hattori Y, Hattori K, Machida T, Matsuda N. Vascular endotheliitis associated with infections: its pathogenetic role and therapeutic implication. Biochem Pharmacol. 2022;197</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8743392</ArticleId><ArticleId IdType="pubmed">35021044</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinaglia T, Shabani M, Breder I, Silber HA, Lima JAC, Sposito AC. Coronavirus disease-19: the multi-level, multi-faceted vasculopathy. Atherosclerosis. 2021;322:39&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7883684</ArticleId><ArticleId IdType="pubmed">33706082</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Z, Li X, Fan RLY, et al. A human pluripotent stem cell-based model of SARS-CoV-2 infection reveals an ACE2-independent inflammatory activation of vascular endothelial cells through TLR4. Stem Cell Reports. 2022 S2213-6711(22)00059-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8851885</ArticleId><ArticleId IdType="pubmed">35180397</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Tecson KM, McCullough PA. Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy. Rev Cardiovasc Med. 2020;21:315&#x2013;319.</Citation><ArticleIdList><ArticleId IdType="pubmed">33070537</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons S, Fodil S, Azoulay E, Zafrani L. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care. 2020;24(1):353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7296907</ArticleId><ArticleId IdType="pubmed">32546188</ArticleId></ArticleIdList></Reference><Reference><Citation>Otifi HM, Adiga BK. Endothelial dysfunction in COVID-19 infection. Am J Med Sci. 2022;363(4):281&#x2013;287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8802031</ArticleId><ArticleId IdType="pubmed">35093394</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Li X, Chen M, Feng Y, Xiong C. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020;116(6):1097&#x2013;1100. Erratum in: Cardiovasc Res. 2020 Oct 1;116:1994.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184507</ArticleId><ArticleId IdType="pubmed">32227090</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Xiao J, Sun R, et al. Prolonged persistence of SARS-CoV-2 RNA in body fluids. Emerg Infect Dis. 2020;26:1834&#x2013;1838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392422</ArticleId><ArticleId IdType="pubmed">32383638</ArticleId></ArticleIdList></Reference><Reference><Citation>Vibholm LK, Nielsen SSF, Pahus MH, et al. SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses. EBioMedicine. 2021;64</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7847186</ArticleId><ArticleId IdType="pubmed">33530000</ArticleId></ArticleIdList></Reference><Reference><Citation>Liotti FM, Menchinelli G, Marchetti S, et al. Assessment of SARS-CoV-2 RNA test results among patients who recovered from COVID-19 with prior negative results. JAMA Intern Med. 2021;181(5):702&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7662488</ArticleId><ArticleId IdType="pubmed">33180119</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl K, Br&#xe4;sen JH, Hoeper MM, David S. Absence of SARS-CoV-2 RNA in COVID-19-associated intestinal endothelialitis. Intensive Care Med. 2021;47:359&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7778861</ArticleId><ArticleId IdType="pubmed">33388837</ArticleId></ArticleIdList></Reference><Reference><Citation>Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111:1805&#x2013;1812.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC161431</ArticleId><ArticleId IdType="pubmed">12813013</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu KK, Thiagarajan P. Role of endothelium in thrombosis and hemostasis. Annu Rev Med. 1996;47:315&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="pubmed">8712785</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniels LB, Clopton P, deFilippi CR, et al. Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA) Am Heart J. 2015;170:1170&#x2013;1183.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4684596</ArticleId><ArticleId IdType="pubmed">26678639</ArticleId></ArticleIdList></Reference><Reference><Citation>Goshua G, Pine AB, Meizlish ML, et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020;7:e575&#x2013;e582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7326446</ArticleId><ArticleId IdType="pubmed">32619411</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermansyah TA, Ginanjar E, Putri VH. Elevation of cardiac biomarkers in COVID-19 as a major determinant for mortality: a systematic review. Acta Med Indones. 2021;53:385&#x2013;396.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027485</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27:258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware JE, Snow KK, Kosinski M, Gandek B. New England Medical Center, The Health Institute; Boston, MA: 1993. SF-36&#xae; Health Survey Manual and Interpretation Guide.</Citation></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan PK, To KF, Lo AW, et al. Persistent infection of SARS coronavirus in colonic cells in vitro. J Med Virol. 2004;74:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7166317</ArticleId><ArticleId IdType="pubmed">15258961</ArticleId></ArticleIdList></Reference><Reference><Citation>Li AM, Chan CH, Chan DF. Long-term sequelae of SARS in children. Paediatr Respir Rev. 2004;5:296&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7106002</ArticleId><ArticleId IdType="pubmed">15531253</ArticleId></ArticleIdList></Reference><Reference><Citation>Tso EY, Tsang OT, Choi KW, et al. Princess Margaret Hospital SARS Study Group. Persistence of physical symptoms in and abnormal laboratory findings for survivors of severe acute respiratory syndrome. Clin Infect Dis. 2004;38:1338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7107853</ArticleId><ArticleId IdType="pubmed">15127357</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;24(11):37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed H, Patel K, Greenwood DC, et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: a systematic review and meta-analysis. J Rehabil Med. 2020;52:jrm00063.</Citation><ArticleIdList><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn SH, Kim JL, Kim JR, et al. Association between chronic fatigue syndrome and suicidality among survivors of Middle East respiratory syndrome over a 2-year follow-up period. J Psychiatr Res. 2021;137:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7888998</ArticleId><ArticleId IdType="pubmed">33631632</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam MH, Wing YK, Yu MW, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009;169:2142&#x2013;2147.</Citation><ArticleIdList><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604(7907):697&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Golia E, Limongelli G, Natale F, et al. Inflammation and cardiovascular disease: from pathogenesis to therapeutic target. Curr Atheroscler Rep. 2014;16:435.</Citation><ArticleIdList><ArticleId IdType="pubmed">25037581</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc7;&#x131;rako&#x11f;lu &#xd6;F, Y&#x131;lmaz AS. Systemic immune-inflammation index is associated with increased carotid intima-media thickness in hypertensive patients. Clin Exp Hypertens. 2021;43:565&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pubmed">33858279</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerging Risk Factors Collaboration. Kaptoge S, Di Angelantonio E, Lowe G, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375(9709):132&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3162187</ArticleId><ArticleId IdType="pubmed">20031199</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucharska-Newton AM, Couper DJ, Pankow JS, et al. Hemostasis, inflammation, and fatal and nonfatal coronary heart disease: long-term follow-up of the atherosclerosis risk in communities (ARIC) cohort. Arterioscler Thromb Vasc Biol. 2009;29:2182&#x2013;2190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3057473</ArticleId><ArticleId IdType="pubmed">19797708</ArticleId></ArticleIdList></Reference><Reference><Citation>Willeit P, Thompson A, Aspelund T, et al. Hemostatic factors and risk of coronary heart disease in general populations: new prospective study and updated meta-analyses. PLoS One. 2013;8:e55175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3567058</ArticleId><ArticleId IdType="pubmed">23408959</ArticleId></ArticleIdList></Reference><Reference><Citation>Clapp BR, Hingorani AD, Kharbanda RK, et al. Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress. Cardiovasc Res. 2004;64(1):172&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pubmed">15364625</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellon X, Bogdanova V. Chronic inflammatory diseases and endothelial dysfunction. Aging Dis. 2016;7:81&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4723236</ArticleId><ArticleId IdType="pubmed">26815098</ArticleId></ArticleIdList></Reference><Reference><Citation>Botts SR, Fish JE, Howe KL. Dysfunctional vascular endothelium as a driver of atherosclerosis: emerging insights into pathogenesis and treatment. Front Pharmacol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727904</ArticleId><ArticleId IdType="pubmed">35002720</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S, Ilyas I, Little PJ, et al. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies. Pharmacol Rev. 2021;73:924&#x2013;967.</Citation><ArticleIdList><ArticleId IdType="pubmed">34088867</ArticleId></ArticleIdList></Reference><Reference><Citation>Bokn&#xe4;s N, Laine C, Hillarp A, et al. Associations between hemostatic markers and mortality in COVID-19 - Compounding effects of D-dimer, antithrombin and PAP complex. Thromb Res. 2022;213:97&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8930184</ArticleId><ArticleId IdType="pubmed">35316719</ArticleId></ArticleIdList></Reference><Reference><Citation>Philippe A, Chocron R, Gendron N, et al. Circulating von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality. Angiogenesis. 2021;24:505&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7809553</ArticleId><ArticleId IdType="pubmed">33449299</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandoval Y, Januzzi JL, Jr, Jaffe AS. Cardiac troponin for assessment of myocardial injury in COVID-19: JACC Review topic of the week. J Am Coll Cardiol. 2020;8;76(10):1244&#x2013;1258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833921</ArticleId><ArticleId IdType="pubmed">32652195</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo-Fern&#xe1;ndez A, Izquierdo A, Subirana I, et al. Markers of myocardial injury in the prediction of short-term COVID-19 prognosis. Rev Esp Cardiol (Engl Ed) 2021;74(7):576&#x2013;583.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7522647</ArticleId><ArticleId IdType="pubmed">33153955</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2022;28(4) 611.e9-611.e16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed MS, Moulin TC, Schioth HB. Sex differences in COVID-19: the role of androgens in disease severity and progression. Endocrine. 2021;71:3e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7657570</ArticleId><ArticleId IdType="pubmed">33179220</ArticleId></ArticleIdList></Reference><Reference><Citation>Bienvenu LA, Noonan J, Wang X, Peter K. Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities. Cardiovasc Res. 2020;116:2197e206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665363</ArticleId><ArticleId IdType="pubmed">33063089</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng F, Dai C, Cai P, et al. A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between sex. J Med Virol. 2020;92:2050&#x2013;2054.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267228</ArticleId><ArticleId IdType="pubmed">32383183</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. WHO coronavirus (COVID-19) dashboard. Available at: https://covid19.who.int/?adgroupsurvey={adgroupsurvey}&amp;gclid=Cj0KCQjw6pOTBhCTARIsAHF23fKJHW3Xbn1sySpayqR5wsJau8WjsSxpXjdXDVM0qGANFq5AqUq1ykgaAoFhEALw_wcB. Accessed March 11, 2023.</Citation></Reference><Reference><Citation>https://www.cdc.gov/mmwr/volumes/70/wr/mm7037a7.htm?s_cid=mm7037a7_w (accessed 24th April, 2022)</Citation></Reference><Reference><Citation>Menyhart O, Weltz B, Gy&#x151;rffy B. MultipleTesting.com: A tool for life science researchers for multiple hypothesis testing correction. PLoS One. 2021;16(6) Erratum in: PLoS One. 2022 Sep 9;17(9):e0274662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8189492</ArticleId><ArticleId IdType="pubmed">34106935</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade C. Multiple testing and protection against a type 1 (False Positive) error using the Bonferroni and Hochberg Corrections. Indian J Psychol Med. 2019;41(1):99&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6337927</ArticleId><ArticleId IdType="pubmed">30783320</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong RA. When to use the Bonferroni correction. Ophthalmic Physiol Opt. 2014;34(5):502&#x2013;508.</Citation><ArticleIdList><ArticleId IdType="pubmed">24697967</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>